Multi-35 Sub-Study C: A Phase 1b/2 Substudy of ASP-1929 Photoimmunotherapy in Combination with Anti-PD1 Therapy in Patients with Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma Who Have Progressed on Anti-PD1 Therapy

Grants and Contracts Details

StatusActive
Effective start/end date11/10/205/15/25

Funding

  • Rakuten Medical Incorporated: $180,585.00